PKC beta Antikörper (Internal Region)

Produktnummer ABIN539471

Produktdetails anti-PKC beta Antikörper

Target: PKC beta (PRKCB) (Protein Kinase C, beta (PRKCB))

Bindungsspezifität: Internal Region

Reaktivität: Human, Ratte, Maus, Affe, Kaninchen, Rind (Kuh)

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser PKC beta Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA

Verwendungszweck: Rabbit polyclonal antibody raised against synthetic peptide of PRKCB.

Kreuzreaktivität: Rind (Kuh), Human, Affe, Maus, Kaninchen, Ratte

Produktmerkmale: Antibody Reactive Against Synthetic Peptide.

Immunogen: A synthetic peptide corresponding to internal region of human PRKCB.

Anwendungsinformationen

Applikationshinweise: ELISA (1:75000-1:80000)
Western Blot (1:1000-1:2000)
The optimal working dilution should be determined by the end user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: In 20 mM KH₂PO₄, 150 mM NaCl, pH 7.2 (0.01 % sodium azide)

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.

Referenzen für anti-PKC beta Antikörper (ABIN539471)

Nakura, Higuchi, Yoshida, Yoshikawa: "PKC? suppresses osteoblastic differentiation." in: Bone, Vol. 48, Issue 3, pp. 476-84, (2011) (PubMed).

Graff, McNulty, Hanna, Konicek, Lynch, Bailey, Banks, Capen, Goode, Lewis, Sams, Huss, Campbell, Iversen, Neubauer, Brown, Musib, Geeganage, Thornton et al.: "The protein kinase Cbeta-selective inhibitor, Enzastaurin (LY317615.HCl), suppresses signaling through the AKT pathway, induces apoptosis, and suppresses growth of human colon cancer and glioblastoma ..." in: Cancer research, Vol. 65, Issue 16, pp. 7462-9, (2005) (PubMed).

Koivunen, Aaltonen, Koskela, Lehenkari, Laato, Peltonen: "Protein kinase C alpha/beta inhibitor Go6976 promotes formation of cell junctions and inhibits invasion of urinary bladder carcinoma cells." in: Cancer research, Vol. 64, Issue 16, pp. 5693-701, (2004) (PubMed).

Details zu PKC beta

Target: PKC beta (PRKCB) (Protein Kinase C, beta (PRKCB))

Andere Bezeichnung: PRKCB (PRKCB Produkte)

Synonyme: PKC-beta antikoerper, PKCB antikoerper, PRKCB1 antikoerper, PRKCB2 antikoerper, A130082F03Rik antikoerper, PKC-Beta antikoerper, Pkcb antikoerper, Prkcb1 antikoerper, Prkcb2 antikoerper, PKC-B antikoerper, Prkcb antikoerper, prkcb1 antikoerper, zgc:63591 antikoerper, PKC antikoerper, PRKCB_tv2 antikoerper, Pkc53E antikoerper, prkcb1l antikoerper, zgc:64063 antikoerper, protein kinase C beta antikoerper, protein kinase C, beta antikoerper, protein kinase C, beta b antikoerper, protein kinase C, beta a antikoerper, PRKCB antikoerper, Prkcb antikoerper, prkcbb antikoerper, prkcba antikoerper

Gen-ID: 5579

Pathways: WNT Signalweg, T-Zell Rezeptor Signalweg, Thyroid Hormone Synthesis, Nuclear Hormone Receptor Binding, Chromatin Binding, Myometrial Relaxation and Contraction, VEGF Signaling, Unfolded Protein Response, BCR Signaling